第三条 公司董事、高级管理人员离职包含任期届满未连任、主动辞职、被解除职 务以及其他导致董事、高级管理人员实际离职等情形。 第四条 董事可以在任期届满之前提出辞职，董事辞职应当向董事会提交书面辞职 报告。 北京莱伯泰科仪器股份有限公司 董事、高级管理人员离职管理制度 北京莱伯泰科仪器股份有限公司 董事、高级管理人员离职管理制度 第一章 总则 第一条 为规范北京莱伯泰科仪器股份有限公司（以下简称"公司"）董事离职程 序，确保公司治理结构的稳定性和连续性，维护公司及股东的合法权益，公司根据《中 华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称 "《证券法》"）、《上市公司章程指引》、《上海证券交易所科创板股票上市规则》等法律 法规及《北京莱伯泰科仪器股份有限公司章程》（以下简称"《公司章程》"）的有关规定， 制定本制度。 第二条 本制度适用于公司董事（含独立董事）及高级管理人员因任期届满、辞职、 被解除职务或其他原因离职的情形。 第二章 离职情形及程序 董事辞职自辞职报告送达董事会时生效，但发生下列情形的，董事辞职报告自下任 董事填补因此辞职产生的空缺后方能生效，原董事仍应当依照 ...

证券代码：688056 证券简称：莱伯泰科 公告编号：2025-026 北京莱伯泰科仪器股份有限公司（以下简称"公司"）于 2025 年 7 月 31 日召 开第五届董事会第二次会议，审议通过了《关于使用暂时闲置募集资金进行现金 管理的议案》，同意公司在保证不影响募集资金投资项目实施、确保募集资金安 全的前提下，使用最高不超过人民币 13,000.00 万元（含本数）的暂时闲置募集 资金进行现金管理，用于购买投资安全性高、流动性好的保本型理财产品（包括 但不限于结构性存款、协定存款、通知存款、定期存款、大额存单、收益凭证等）， 自公司董事会审议通过之日起 12 个月内有效。在前述额度及期限范围内，资金 可以循环滚动使用。董事会授权董事长在授权额度和期限内行使投资决策权及签 署相关法律文件等，具体事项由公司财务部负责组织实施。 一、募集资金基本情况 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2020 年 8 月 4 日出具的《关于同意北京莱伯泰科仪器股份有限公司首次公开发行股票注册的批 复》（证监许可[2020]1657 号），公司获准向社会公开发行人民币普通股 1,700 万 股，每股发行价格为 ...

证券代码：688056 证券简称：莱伯泰科 公告编号：2025-029 北京莱伯泰科仪器股份有限公司 第五届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 北京莱伯泰科仪器股份有限公司（以下简称"公司"）第五届董事会第二次 会议通知于 2025 年 7 月 25 日以书面形式发出，并于 2025 年 7 月 31 日在公司会 议室以现场与通讯相结合的方式召开。会议应出席董事 7 人，实际出席董事 7 人。公司高级管理人员列席了会议。 会议由董事长胡克先生召集并主持。会议的召开符合有关法律、行政法规、 部门规章和《北京莱伯泰科仪器股份有限公司章程》（以下简称"《公司章程》"） 的规定，合法有效。 二、董事会会议审议情况 经与会董事认真审议，会议形成了如下决议： （一）审议通过《关于使用暂时闲置募集资金进行现金管理的议案》 经审议，公司董事会同意公司在保证不影响募集资金投资项目实施、确保募 集资金安全的前提下，使用最高不超过人民币 13,000.00 万元（含本数）的暂时 闲置 ...

Group 1 - The company, 莱伯泰科 (688056.SH), announced a plan to use its own funds for cash management, with a maximum amount not exceeding RMB 350 million [1] - The cash management plan will have a usage period of no more than 12 months [1] - Within the specified limit and duration, the funds can be used in a revolving manner [1]

Core Viewpoint - The article discusses the current procurement trends and market dynamics of ICP-MS (Inductively Coupled Plasma Mass Spectrometry) instruments, highlighting the increasing demand for both imported and domestic brands in the customs sector of China [3][4][6]. Group 1: Market Overview - The ICP-MS instruments are experiencing a new wave of procurement, particularly in the customs sector, driven by the need for enhanced detection capabilities for import and export goods [3][4]. - From November 2024 to the present, there have been 44 procurement announcements for ICP-MS, totaling 45 units with a combined bid amount exceeding 56.35 million yuan [3][4]. Group 2: Regional Distribution - The East China region shows the highest demand for ICP-MS, with 25 units procured, accounting for 56% of total purchases. Key provinces include Shandong, Jiangsu, and Fujian [4]. - The South China region follows with 7 units (16%), while the Northwest region accounts for 5 units (11%) [4]. Group 3: Brand Performance - The procurement data includes 6 brands of ICP-MS, with both imported and domestic brands having equal representation. The leading imported brands are Agilent, PerkinElmer, and Thermo Fisher, while the domestic brands include Puyutech, Labtech, and Hengsheng [6][10]. - Agilent leads the market with a 48% share, followed by PerkinElmer at 26%, and Thermo Fisher at 12%. Domestic brands are also gaining traction, indicating a trend towards domestic substitution [10][13]. Group 4: Popular Models - The most popular models during the procurement period include Agilent's 7850, PerkinElmer's NexION 1100G, and Thermo Fisher's iCAP RQ Plus among imported brands. For domestic brands, Puyutech's SUPEC 7000, Labtech's LabMS 3000, and Hengsheng's iQuad 2300 are notable [14][15].

Industry Rating - The report maintains an "Outperform" rating for the scientific instruments industry, consistent with the previous rating [1]. Core Insights - The scientific instruments market in China surpassed 220 billion yuan in 2023, with a growth rate exceeding 12%. The market is dominated by high-end foreign brands, and there is a significant push for domestic alternatives driven by government policies [2][12]. - The domestic market for mass spectrometers reached 16.712 billion yuan in 2023, with foreign companies holding over 90% of the global market share. The import rate for mass spectrometers has decreased from 89% in 2018 to 81% in 2023, indicating a gradual shift towards domestic production [3][41]. - The electronic measurement instruments market is projected to exceed 40 billion yuan in 2024, with a notable focus on mid-to-high-end products. The market for oscilloscopes is expected to reach 650 million USD by 2025 [4]. Summary by Sections 1. Scientific Instruments Industry - The scientific instruments industry is characterized by high-end foreign brands dominating the market, while domestic brands struggle to gain market share. The government has introduced various policies to promote domestic innovation and application of scientific instruments [2][24]. 2. Scientific Analysis Instruments - The market for scientific analysis instruments is vast, with mass spectrometers and chromatographs showing low domestic production rates. The mass spectrometer market is expected to grow significantly, with a focus on high-resolution and triple quadrupole models as key areas for domestic manufacturers to target [25][50]. 3. Electronic Measurement Instruments - The electronic measurement instruments market is rapidly expanding, with a projected market size of 16.307 billion USD globally by 2024. The domestic market is expected to exceed 40 billion yuan, with a significant portion of high-end products still being imported [4][6]. 4. Policy Guidance - Recent government policies have aimed to support the development of domestic scientific instruments, including tax exemptions for imported instruments used in research and education, which will lower costs for research institutions [21][24].

Core Viewpoint - The article highlights significant developments in the scientific instrument industry, including policy changes, product innovations, and collaborations aimed at enhancing research capabilities and industry standards [2][4][11]. Policy and Industry Standards - Sichuan Province has implemented a new policy for sharing major scientific research infrastructure and large scientific instruments, mandating that instruments valued at 500,000 yuan or more be included in a provincial sharing platform, effective July 18, 2025 [2]. Manufacturer Dynamics and New Product Releases - Suzhou Bozhong Instrument Technology Co., Ltd. launched China's first commercial 200 kV field emission transmission electron microscope (TEM) with a point resolution of 0.25 nanometers, targeting semiconductor wafer defect detection and lithium battery analysis [4]. - Shanghai Yidian Scientific Instruments participated in CPHI China 2025, showcasing GMP-compliant titrators, moisture analyzers, and spectroscopic chromatography instruments, along with providing 3Q certification services [5][6]. - Zhuomao Technology released the AXI9000, a high-speed CT X-ray automatic detection device, addressing the limitations of traditional 2D detection for 3D defect inspection in the electronics manufacturing sector [7]. - Leibertai Technology reported that its mass spectrometer series has competitive core performance indicators, with plans to accelerate import substitution through mergers and acquisitions [8]. - Huizhou Huagao Instruments introduced the DM&S SMS-1000 flash point tester, utilizing multi-point non-destructive testing technology, achieving over a 50% reduction in error rates compared to traditional methods [9]. Laboratory and Research Collaborations - Anhui Yi Technology and Hefei Comprehensive National Science Center signed an agreement to establish a joint laboratory for the development of key vacuum measurement equipment for nuclear fusion [11]. - The Hunan Provincial Drug Inspection Institute successfully passed the CNAS address change review, enhancing its testing capabilities for pharmaceuticals and medical devices [12]. - The Chenzhou Laboratory aims to optimize research models through industry-academia collaboration, focusing on key technologies to meet enterprise needs [13]. - A partnership between Heilongjiang Province's environmental monitoring center and Heilongjiang University aims to cultivate 200 interdisciplinary technical talents over three years to support ecological monitoring [14]. Patents and Technological Breakthroughs - Hunan Shuikoushan Nonferrous Metals Group obtained a patent for a method to determine silver, platinum, and palladium in high-silver gray powder, achieving a detection error of less than 0.3% and reducing chemical reagent consumption by 90% [17]. - Jiangsu Luben Instruments applied for a patent for an ion source structure and processing equipment, enhancing production capacity while reducing equipment size and process costs [17]. - Various companies, including Suzhou Fushida and Tianjin Jianzhijian Testing, have obtained patents for innovative testing devices, improving measurement accuracy and efficiency in their respective fields [19][20]. Standards and Testing Technologies - The first domestic standard for fluoroquinolone drug sensitivity testing was published, providing a technical basis for treating multi-drug resistant bacterial infections [24]. - Ningxia has approved seven group standards aimed at improving detection efficiency and accuracy in food testing and microbiological technology [25]. - An international standard for testing the microwave reheating suitability of ceramic tableware was released, ensuring safety in food packaging applications [26]. Industry Events and Activities - The "Rong Craftsman Cup" skill competition for the seasoning industry was launched to accelerate technological upgrades and talent cultivation in Sichuan Province [28]. - DXOMARK released a new benchmark for smartphone imaging tests, enhancing evaluation standards for HDR, zoom, and video shooting [29]. - The Laser World of Photonics 2025 event in Munich showcased advanced optical instruments and solutions, attracting professionals from various countries [30]. - The China International Optical Instruments Exhibition is set to take place, featuring a high-profile forum on optical technology and applications [31].

Core Viewpoint - The report outlines the equity changes of LabTech Holdings, Inc. and its affiliates in Beijing LabTech Instrument Co., Ltd., indicating a reduction in their shareholding percentage due to passive dilution and a share transfer [7][10][21]. Group 1: Equity Change Details - The equity change is attributed to passive dilution from the increase in total share capital due to the vesting of restricted stock and a share transfer by Beijing LabTech Management Consulting Co., Ltd. [7][8] - The shareholding percentage of the information disclosing party decreased from 60.89% to 57.48% following the transfer of 2,023,573 shares, which represents 3.00% of the total share capital [10][22]. - The total share capital increased by 198,600 shares on June 16, 2022, 37,800 shares on December 16, 2022, and 216,060 shares on November 13, 2024, leading to a passive dilution of the shareholding percentage [9][27]. Group 2: Share Transfer Process - The share transfer was conducted through a price inquiry, with the final transfer price set at 29.19 yuan per share [20][30]. - A total of 411 institutional investors were invited to participate in the inquiry, with 20 valid bids received from 17 participating institutions [29][30]. - The transfer does not result in a change of control for the company, as the controlling shareholder remains the same [21][30].

Core Viewpoint - The report outlines a significant change in the shareholding structure of Beijing LabTech Instrument Co., Ltd, indicating a passive dilution of shares and a reduction in the overall ownership percentage of the information disclosing parties from 60.89% to 57.48% due to stock incentive plans and share transfers [1][5][6]. Group 1: Shareholding Changes - The shareholding percentage of the information disclosing parties decreased from 60.89% to 57.48% as a result of passive dilution and a share transfer by Beijing LabTech Management Consulting Co., Ltd [5][6]. - The total number of shares held by the information disclosing parties before the transfer was 40,795,000, which represented 60.89% of the total issued shares. After the transfer, the number of shares decreased to 38,771,427, representing 57.48% of the total issued shares [8][14]. Group 2: Share Transfer Details - The share transfer involved a total of 2,023,573 shares, which were sold through a price inquiry transfer method [6][7]. - The share transfer was executed on June 13, 2025, and was part of a broader strategy to meet the financial needs of the transferring party [5][6]. Group 3: Future Plans - As of the report date, there are no definitive plans from the information disclosing parties to increase or decrease their shareholding in the next 12 months, although such actions are not ruled out [5][14]. - The information disclosing parties have committed to adhering to relevant laws and regulations regarding any future shareholding changes [5][14].

Core Viewpoint - The report details the results of a share transfer by Beijing Laibotai Technology Instrument Co., Ltd., indicating a decrease in the shareholding percentage of its controlling shareholder, Beijing Laibotai Management Consulting Co., Ltd., from 60.89% to 57.48% following the transfer of 2,023,573 shares at a price of 29.19 yuan per share [1][2][5]. Summary by Sections 1. Transfer Details - The share transfer price was set at 29.19 yuan per share, with a total of 2,023,573 shares being transferred [1]. - The controlling shareholder, Beijing Laibotai Management Consulting Co., Ltd., did not participate in the transfer through its indirect holdings [1]. - The transfer is classified as a passive dilution and will not result in a change of control for the company [1][5]. 2. Shareholder Information - As of June 9, 2025, the shareholding structure shows that the transferor, Beijing Laibotai Management Consulting Co., Ltd., held 24,177,000 shares, representing 35.84% of the total shares before the transfer [2]. - After the transfer, the shareholding percentage of the management consulting firm and its concerted actors decreased to 57.48% [2][3]. 3. Transfer Process - The transfer was conducted through an inquiry process, with a price determined based on the average trading price of the stock over the previous 20 trading days [5]. - A total of 411 institutional investors received the subscription invitation, with 20 valid bids received from 17 participating institutions [5]. - The final allocation of shares was made to five investors, confirming the transfer price of 29.19 yuan per share [5]. 4. Regulatory Compliance - The transfer process adhered to relevant laws and regulations, ensuring fairness and compliance with market standards [7].